In this small study conducted by researchers from Mashhad University, with assistance from researchers at the Slovak Academy of Medicine, a mouse model of colitis was induced, and then treated with either sulfasalazine, a standard approved drug, hydrogen water created by Drink HRW tablets, or both sulfasalazine and Drink HRW tablets. The hydrogen tablets demonstrated a significant benefit in protection against the colitis model, comparable to the approved medication sulfasalazine. Further, the combination of hydrogen water and the drug sulfasalazine proved to be significantly more effective than hydrogen water, or sulfasalazine, on their own. This study is another positive glimpse at the research utilizing hydrogen tablets as an adjuvant therapy alongside standard care.